Abstract
The rapid development of several safe and effective vaccines against COVID-19 was the cornerstone of the pandemic control. However, inequality in vaccine distribution and the emergence of new variants of concern (VOCs) highlighted significant gaps in the global strategy for mitigating SARS-CoV-2 infection. Despite the use of different platforms, most approved vaccines use the Spike protei…